Search results
Results from the WOW.Com Content Network
Crescent Capital Group is a global alternative investment firm focused on below investment grade credit markets with primary strategies that include funds that invest in leveraged loans, high-yield bonds, mezzanine debt, special situations, and distressed securities.
Before Cover-More went public, Crescent Capital Partners owned 82.7 percent of the company. Crescent Capital would own 13 percent of the company after the initial public offering (IPO) in December 2013. [9] [10] At that time, it was the first and only Australian travel insurance provider to list on the Australian Stock Exchange. [11]
In July 2015 Healthscope sold its Australian Pathology division to Crescent Capital Partners. [2] In August 2017, Healthscope sold their Medical Centres portfolio to Singapore-based Fullerton Healthcare. [3] On 6 June 2019, Canadian firm Brookfield Business Partners LLP announced completion of its takeover of Healthscope. [4]
Investment company Crescent Capital Consulting, LLC (Current Portfolio) buys iShares TIPS Bond ETF, Invesco BulletShares 2024 High Yield Corporate Bon, SPDR S&P Bank ETF, BTC iShares MSCI USA Min ...
Crescent Capital BDC (CCAP) delivered earnings and revenue surprises of 2.44% and 0.42%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
For premium support please call: 800-290-4726 more ways to reach us
From 1983 until 1991, Beyer was an investment banker and capital markets professional at Bear, Stearns & Co. and Drexel Burnham Lambert. [6] At Drexel, he worked directly under Michael Milken, a pioneer in the financing of American businesses. [7] Beyer was one of the individuals responsible for managing Drexel through its bankruptcy in 1990 ...
Crescent Capital BDC (CCAP) delivered earnings and revenue surprises of -2.33% and 0.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the ...